We are live on ! Find out more
QCOR

QUESTCOR PHARMA INC
QCOR

Delisted

QCOR was delisted on the 14th of August, 2014.

320 hedge funds and large institutions have $6.07B invested in QUESTCOR PHARMA INC in 2014 Q2 according to their latest regulatory filings, with 86 funds opening new positions, 68 increasing their positions, 142 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more funds holding in top 10

Funds holding in top 10: 817 (+9)

50% more capital invested

Capital invested by funds: $4.06B → $6.07B (+$2.01B)

2% more funds holding

Funds holding: 313320 (+7)

9% more first-time investments, than exits

New positions opened: 86 | Existing positions closed: 79

52% less repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 142

79% less call options, than puts

Call options by funds: $349M | Put options by funds: $1.67B

Holders
320
Holders Change
+7
Holders Change %
+2.24%
% of All Funds
9.2%
Holding in Top 10
17
Holding in Top 10 Change
+9
Holding in Top 10 Change %
+112.5%
% of All Funds
0.49%
New
86
Increased
68
Reduced
142
Closed
79
Calls
$349M
Puts
$1.67B
Net Calls
-$1.32B
Net Calls Change
-$1.12B
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity International
26
Fidelity International
Bermuda
$73.2M +$5.36M +62,644 +9%
SC
27
Sculptor Capital
New York
$60.4M +$56M +653,438 New
Northern Trust
28
Northern Trust
Illinois
$59.1M -$27.3M -319,132 -33%
PSAMP
29
P. Schoenfeld Asset Management (PSAM)
New York
$56.5M +$52.3M +611,064 New
JP Morgan Chase
30
JP Morgan Chase
New York
$53.9M +$5.18M +60,518 +12%
Deutsche Bank
31
Deutsche Bank
Germany
$52M +$14.4M +168,070 +43%
Invesco
32
Invesco
Georgia
$51.4M -$20.9M -243,752 -30%
Allianz Asset Management
33
Allianz Asset Management
Germany
$51.3M +$16.2M +188,773 +52%
WIC
34
Water Island Capital
New York
$50.4M +$46.6M +544,444 New
Goldman Sachs
35
Goldman Sachs
New York
$49.1M -$21.9M -255,957 -33%
D.E. Shaw & Co
36
D.E. Shaw & Co
New York
$48.5M +$33.7M +394,020 +301%
CS
37
Credit Suisse
Switzerland
$48.2M -$12.9M -150,817 -22%
BBA
38
Baker Bros. Advisors
New York
$46.2M -$18.6M -217,745 -30%
TA
39
Teachers Advisors
New York
$40.9M -$45.5M -530,786 -55%
PA
40
Perceptive Advisors
New York
$37M +$31.8M +371,400 +1,299%
GP
41
GLG Partners
United Kingdom
$35.3M +$32.7M +381,510 New
Alyeska Investment Group
42
Alyeska Investment Group
Illinois
$33.8M +$31.3M +365,664 New
Principal Financial Group
43
Principal Financial Group
Iowa
$33.5M +$718K +8,386 +2%
MP
44
Manikay Partners
New York
$30.9M +$28.6M +334,448 New
GAM
45
Gotham Asset Management
New York
$29.6M -$1.35M -15,769 -5%
U
46
UBS
Switzerland
$29.3M +$15.8M +184,832 +140%
Fidelity Investments
47
Fidelity Investments
Massachusetts
$29.3M -$306M -3,567,813 -92%
AC
48
Argentiere Capital
Switzerland
$29.2M +$27M +315,468 New
AGC
49
Angelo Gordon & Co
New York
$27.7M +$25.7M +300,000 New
AAA
50
Alpine Associates Advisors
New Jersey
$27.7M +$25.6M +299,400 New

QCOR Hedge Fund Activity: Q2 2014 in Review

320 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in QUESTCOR PHARMA INC (QCOR) for Q2 2014, worth a combined $6.07B — up 50% from $4.06B a quarter earlier.

Buyers outnumbered sellers: 86 funds opened new QCOR positions and 79 closed out — a net gain of 7 holders — while 68 added to existing stakes and 142 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $378M. The largest seller was Fidelity Investments, cutting an estimated $306M.

  • 320 institutional investors held QUESTCOR PHARMA INC (QCOR) as of Q2 2014, up from 313 in Q1 2014.
  • Funds reported $6.07B of QUESTCOR PHARMA INC stock for Q2 2014, up 50% quarter-over-quarter.
  • 86 funds opened new QUESTCOR PHARMA INC positions in Q2 2014 and 79 closed out, a net change of +7 holders.
  • The largest QUESTCOR PHARMA INC buyer in Q2 2014 was Adage Capital Partners, an estimated $378M added.
  • The largest QUESTCOR PHARMA INC seller in Q2 2014 was Fidelity Investments, an estimated $306M sold.

Based on aggregated 13F filings for Q2 2014.